CDKN2A and astrocytoma (excluding glioblastoma): In the case of H3-mutant, IDH-wildtype and IDH-mutant astrocytoma/glioblastoma this pathway is perturbed close to the source via the direct loss of RB, p53 or p16INK4a protein function.